Company Windtree Therapeutics Inc Nasdaq
Equities
US97382D1054
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Eric Curtis
COO | Chief Operating Officer | 56 | 20-03-08 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Steven Simonson
CTO | Chief Tech/Sci/R&D Officer | 65 | 14-05-19 |
Jamie McAndrew
AUD | Comptroller/Controller/Auditor | 44 | 13-10-31 |
Diane Carman
LAW | General Counsel | 55 | 21-06-30 |
Tracy Rarick
PRN | Corporate Officer/Principal | - | 20-07-20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 21-02-02 |
Mark Strobeck
BRD | Director/Board Member | 53 | 23-06-21 |
Leslie Williams
BRD | Director/Board Member | 64 | 21-02-02 |
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 510,178 | 486,423 ( 95.34 %) | 0 ( 0.000011 %) | 95.34 % |
Company contact information
Windtree Therapeutics, Inc.
2600 Kelly Road Suite 100
18976-3622, Warrington
+
http://www.windtreetx.comSector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |